Matches in SemOpenAlex for { <https://semopenalex.org/work/W2240026871> ?p ?o ?g. }
- W2240026871 endingPage "12" @default.
- W2240026871 startingPage "1705" @default.
- W2240026871 abstract "The aim of our study was to characterize a model of human prostaglandin endoperoxide synthase-2 (PGHS-2) expression allowing the assessment of pharmacological inhibition in vitro and ex vivo. Heparinized human whole blood samples were incubated with lipopolysaccharide (LPS, 0.1-50 micrograms/ml) for 0 to 24 hr at 37 degrees C. The contribution of platelet PGHS-1 was suppressed by either pretreating the subjects with aspirin (300 mg 48 hr before sampling) or adding aspirin (10 micrograms/ml) in vitro at time 0. PGE2 was measured by radioimmunoassay. LPS induced expression of cyclooxygenase activity in a time- and concentration-dependent fashion. After 24 hr at 10 micrograms/ml LPS, PGE2 production averaged 12.1 +/- 6.2 ng/ml (mean +/- S.D., n = 7). Cyclooxygenase activity increased in parallel with the mass of a monocyte protein doublet analyzed by Western blot using antibodies directed against the carboxyl-terminal portion of human PGHS-2. Dexamethasone (2 microM) inhibited LPS-induced PGE2 production by 96 +/- 4% (mean +/- S.D., n = 3). Four different inhibitors were tested in vitro on the cyclooxygenase activity of LPS-induced monocyte PGH-2 and thrombin-stimulated platelet PGHS-1. IC50 values (microM) for inhibition of PGHS-1 and PGHS-2 were: indomethacin, 0.70 +/- 0.20 vs 0.36 +/- 0.10 (P < .05); S-indobufen, 0.64 +/- 0.22 vs. 14.9 +/- 8 (P < .05), R-indobufen, 38 +/- 18 vs. 230 +/- 68 (P < .01), 6-methoxy-2-naphthyl acetic acid (the active metabolite of nabumetone), 278 +/- 96 vs. 187 +/- 96.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2240026871 created "2016-06-24" @default.
- W2240026871 creator A5006312872 @default.
- W2240026871 creator A5007857718 @default.
- W2240026871 creator A5016103963 @default.
- W2240026871 creator A5016790368 @default.
- W2240026871 creator A5022698160 @default.
- W2240026871 creator A5031961333 @default.
- W2240026871 creator A5045933326 @default.
- W2240026871 creator A5071758568 @default.
- W2240026871 creator A5076651597 @default.
- W2240026871 creator A5088588580 @default.
- W2240026871 date "1994-12-01" @default.
- W2240026871 modified "2023-09-26" @default.
- W2240026871 title "Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases." @default.
- W2240026871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7996488" @default.
- W2240026871 hasPublicationYear "1994" @default.
- W2240026871 type Work @default.
- W2240026871 sameAs 2240026871 @default.
- W2240026871 citedByCount "142" @default.
- W2240026871 countsByYear W22400268712012 @default.
- W2240026871 countsByYear W22400268712013 @default.
- W2240026871 countsByYear W22400268712014 @default.
- W2240026871 countsByYear W22400268712015 @default.
- W2240026871 countsByYear W22400268712016 @default.
- W2240026871 countsByYear W22400268712017 @default.
- W2240026871 countsByYear W22400268712018 @default.
- W2240026871 countsByYear W22400268712019 @default.
- W2240026871 countsByYear W22400268712020 @default.
- W2240026871 countsByYear W22400268712022 @default.
- W2240026871 countsByYear W22400268712023 @default.
- W2240026871 crossrefType "journal-article" @default.
- W2240026871 hasAuthorship W2240026871A5006312872 @default.
- W2240026871 hasAuthorship W2240026871A5007857718 @default.
- W2240026871 hasAuthorship W2240026871A5016103963 @default.
- W2240026871 hasAuthorship W2240026871A5016790368 @default.
- W2240026871 hasAuthorship W2240026871A5022698160 @default.
- W2240026871 hasAuthorship W2240026871A5031961333 @default.
- W2240026871 hasAuthorship W2240026871A5045933326 @default.
- W2240026871 hasAuthorship W2240026871A5071758568 @default.
- W2240026871 hasAuthorship W2240026871A5076651597 @default.
- W2240026871 hasAuthorship W2240026871A5088588580 @default.
- W2240026871 hasConcept C104317684 @default.
- W2240026871 hasConcept C126322002 @default.
- W2240026871 hasConcept C134018914 @default.
- W2240026871 hasConcept C1621761 @default.
- W2240026871 hasConcept C176685330 @default.
- W2240026871 hasConcept C181199279 @default.
- W2240026871 hasConcept C185592680 @default.
- W2240026871 hasConcept C202751555 @default.
- W2240026871 hasConcept C2776415932 @default.
- W2240026871 hasConcept C2777477808 @default.
- W2240026871 hasConcept C2777628954 @default.
- W2240026871 hasConcept C2777752497 @default.
- W2240026871 hasConcept C2778078955 @default.
- W2240026871 hasConcept C2778754761 @default.
- W2240026871 hasConcept C2779689624 @default.
- W2240026871 hasConcept C2780664492 @default.
- W2240026871 hasConcept C2781080829 @default.
- W2240026871 hasConcept C2781184567 @default.
- W2240026871 hasConcept C55493867 @default.
- W2240026871 hasConcept C71924100 @default.
- W2240026871 hasConcept C86803240 @default.
- W2240026871 hasConcept C89560881 @default.
- W2240026871 hasConcept C98274493 @default.
- W2240026871 hasConceptScore W2240026871C104317684 @default.
- W2240026871 hasConceptScore W2240026871C126322002 @default.
- W2240026871 hasConceptScore W2240026871C134018914 @default.
- W2240026871 hasConceptScore W2240026871C1621761 @default.
- W2240026871 hasConceptScore W2240026871C176685330 @default.
- W2240026871 hasConceptScore W2240026871C181199279 @default.
- W2240026871 hasConceptScore W2240026871C185592680 @default.
- W2240026871 hasConceptScore W2240026871C202751555 @default.
- W2240026871 hasConceptScore W2240026871C2776415932 @default.
- W2240026871 hasConceptScore W2240026871C2777477808 @default.
- W2240026871 hasConceptScore W2240026871C2777628954 @default.
- W2240026871 hasConceptScore W2240026871C2777752497 @default.
- W2240026871 hasConceptScore W2240026871C2778078955 @default.
- W2240026871 hasConceptScore W2240026871C2778754761 @default.
- W2240026871 hasConceptScore W2240026871C2779689624 @default.
- W2240026871 hasConceptScore W2240026871C2780664492 @default.
- W2240026871 hasConceptScore W2240026871C2781080829 @default.
- W2240026871 hasConceptScore W2240026871C2781184567 @default.
- W2240026871 hasConceptScore W2240026871C55493867 @default.
- W2240026871 hasConceptScore W2240026871C71924100 @default.
- W2240026871 hasConceptScore W2240026871C86803240 @default.
- W2240026871 hasConceptScore W2240026871C89560881 @default.
- W2240026871 hasConceptScore W2240026871C98274493 @default.
- W2240026871 hasIssue "3" @default.
- W2240026871 hasLocation W22400268711 @default.
- W2240026871 hasOpenAccess W2240026871 @default.
- W2240026871 hasPrimaryLocation W22400268711 @default.
- W2240026871 hasRelatedWork W2037620940 @default.
- W2240026871 hasRelatedWork W2077329550 @default.
- W2240026871 hasRelatedWork W2118644391 @default.
- W2240026871 hasRelatedWork W2240026871 @default.
- W2240026871 hasRelatedWork W2317069681 @default.
- W2240026871 hasRelatedWork W2327786360 @default.